Syntaphilin Regulates Epithelial-Mesenchymal Transition and Metastasis in Gastric Cancer via the FAK/NF-κB/MMP-9 Signaling Pathway
Open Access
- 23 July 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (15) , 6564
Abstract
Syntaphilin (SNPH), initially considered a neuron-specific protein, has recently been found to be widely expressed across various cancers. Mechanistically, SNPH inhibits mitochondrial transport to the cortical cytoskeleton, thereby suppressing cancer cell migration and metastasis. Although SNPH is known to participate in the metastatic progression of multiple malignancies, its precise underlying mechanism remains obscure. In this study, we investigated the role of SNPH in the epithelial–mesenchymal transition (EMT) and invasiveness of gastric cancer cells. Knockdown of SNPH in SNU-638 gastric cancer cells significantly enhanced their migratory and invasive capacities by approximately 1.4-fold and 2.5-fold, respectively. This knockdown concurrently increased focal adhesion kinase (FAK) phosphorylation, upregulated the EMT marker vimentin, and increased the expression of key EMT-related transcription factors, including Snail, Slug, and Twist. Furthermore, SNPH depletion induced the phosphorylation of nuclear factor kappa B (NF-κB), a transcription factor regulating matrix metalloproteinase-9 (MMP-9), which subsequently upregulated MMP-9 mRNA expression. This cascade promotes extracellular matrix degradation, thereby increasing metastatic potential. Notably, these phenotypic and molecular changes were completely reversed upon SNPH overexpression in SNU-638 cells. Taken together, our results demonstrate that SNPH deficiency enhances the migration and metastatic potential of gastric cancer cells by driving EMT and invasion via the FAK/NF-κB/MMP-9 signaling pathway. Consequently, we propose that SNPH represents a novel biomarker and a promising therapeutic target for mitigating gastric cancer metastasis.Keywords
Funding Information
- Daejeon University (Daejeon University Research Grants (2023))
This publication has 56 references indexed in Scilit:
- Epithelial–Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical ImplicationsMedcomm, 2025
- Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer MetastasisCellular and Molecular Bioengineering, 2021
- The epithelial–mesenchymal transition regulators Twist, Slug, and Snail are associated with aggressive tumour features and poor outcome in prostate cancer patientsThe Journal of Pathology: Clinical Research, 2021
- Epithelial to mesenchymal transition inducing transcription factors and metastatic cancerTumor Biology, 2014
- Epithelial‐to‐mesenchymal transition predicts prognosis in clinical gastric cancerJournal of Surgical Oncology, 2014
- Identifying the Regulative Role of NF-κB Binding Sites Within Promoter Region of Human Matrix Metalloproteinase 9 (mmp-9) by TNF-α InductionApplied Biochemistry and Biotechnology, 2012
- Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancerClinical & Experimental Metastasis, 2012
- Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancerGastric Cancer, 2011
- Metastasis-induction and apoptosis-protection by TWIST in gastric cancer cellsClinical & Experimental Metastasis, 2009
- Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down‐regulation of E‐cadherinThe Journal of Pathology, 2007